{"id":"https://openalex.org/W2557548907","doi":"https://doi.org/10.1182/blood.v124.21.1523.1523","title":"Once-Weekly Prophylactic Treatment Versus on-Demand Treatment of Nonacog Alfa in Patients with Moderately Severe to Severe Hemophilia B","display_name":"Once-Weekly Prophylactic Treatment Versus on-Demand Treatment of Nonacog Alfa in Patients with Moderately Severe to Severe Hemophilia B","publication_year":2014,"publication_date":"2014-12-06","ids":{"openalex":"https://openalex.org/W2557548907","doi":"https://doi.org/10.1182/blood.v124.21.1523.1523","mag":"2557548907"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v124.21.1523.1523","doi":"https://doi.org/10.1182/blood.v124.21.1523.1523","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.1523.1523","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085306795","display_name":"Kaan Kavakl\u0131","orcid":"https://orcid.org/0000-0002-4910-2142","observed_orcids":["https://orcid.org/0000-0002-4910-2142"]},"institutions":[{"id":"https://openalex.org/I4210163725","display_name":"Ege \u00dcniversitesi T\u0131p Fak\u00fcltesi Hastanesi","ror":"https://ror.org/05xv0p989","country_code":"TR","type":"healthcare","lineage":["https://openalex.org/I4210163725"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Kaan Kavakli","raw_affiliation_strings":["Ege University Hospital, IZMIR, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ege University Hospital, IZMIR, Turkey","institution_ids":["https://openalex.org/I4210163725"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lynne Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lynne Smith","raw_affiliation_strings":["Pfizer Inc., Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., Collegeville, PA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016197132","display_name":"Kazimierz Kuliczkowski","orcid":"https://orcid.org/0000-0001-6812-1421","observed_orcids":["https://orcid.org/0000-0001-6812-1421"]},"institutions":[{"id":"https://openalex.org/I385303915","display_name":"Wroclaw Medical University","ror":"https://ror.org/01qpw1b93","country_code":"PL","type":"education","lineage":["https://openalex.org/I385303915"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Kazimierz Kuliczkowski","raw_affiliation_strings":["Wroclaw Medical University, Wroclaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wroclaw Medical University, Wroclaw, Poland","institution_ids":["https://openalex.org/I385303915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050194925","display_name":"Joan M Korth-Bradley","orcid":"https://orcid.org/0000-0003-2436-9833","observed_orcids":["https://orcid.org/0000-0003-2436-9833"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joan Korth-Bradley","raw_affiliation_strings":["Pfizer Inc., Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., Collegeville, PA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089145301","display_name":"Chur Woo You","orcid":"https://orcid.org/0000-0002-6156-2520","observed_orcids":["https://orcid.org/0000-0002-6156-2520"]},"institutions":[{"id":"https://openalex.org/I165028127","display_name":"Konyang University","ror":"https://ror.org/02v8yp068","country_code":"KR","type":"education","lineage":["https://openalex.org/I165028127"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Chur Woo You","raw_affiliation_strings":["Konyang University, Daejeon, South Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Konyang University, Daejeon, South Korea","institution_ids":["https://openalex.org/I165028127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077240330","display_name":"Joanne Fuiman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joanne Fuiman","raw_affiliation_strings":["Pfizer Inc., Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., Collegeville, PA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082757602","display_name":"Silva Zupan\u010di\u0107\u2010\u0160alek","orcid":"https://orcid.org/0000-0002-6244-2336","observed_orcids":["https://orcid.org/0000-0002-6244-2336"]},"institutions":[{"id":"https://openalex.org/I138937732","display_name":"University Hospital Centre Zagreb","ror":"https://ror.org/00r9vb833","country_code":"HR","type":"healthcare","lineage":["https://openalex.org/I138937732"]}],"countries":["HR"],"is_corresponding":false,"raw_author_name":"Silva Zupancic-Salek","raw_affiliation_strings":["Univeristy Hospital Centre Rebro, Zagreb, Croatia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univeristy Hospital Centre Rebro, Zagreb, Croatia","institution_ids":["https://openalex.org/I138937732"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048740921","display_name":"Faraizah Abdul Karim","orcid":"https://orcid.org/0000-0001-6954-2906","observed_orcids":["https://orcid.org/0000-0001-6954-2906"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Faraizah Abdul Karim","raw_affiliation_strings":["National Blood Centre, Kuala Lumpur, Malaysia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Blood Centre, Kuala Lumpur, Malaysia","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031859951","display_name":"Pablo Rendo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pablo Rendo","raw_affiliation_strings":["Pfizer Inc., Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., Collegeville, PA","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.2123,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.54228406,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"124","issue":"21","first_page":"1523","last_page":"1523"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hemophilia-b","display_name":"hemophilia B","score":0.9940000176429749},{"id":"https://openalex.org/keywords/factor-ix-replacement-therapy","display_name":"factor IX replacement therapy","score":0.6899999976158142},{"id":"https://openalex.org/keywords/secondary-prophylaxis","display_name":"secondary prophylaxis","score":0.8840000033378601},{"id":"https://openalex.org/keywords/on-demand-treatment","display_name":"on-demand treatment","score":0.9580000042915344},{"id":"https://openalex.org/keywords/annualized-bleeding-rate","display_name":"annualized bleeding rate","score":0.9909999966621399},{"id":"https://openalex.org/keywords/bleeding-events","display_name":"bleeding events","score":0.41499999165534973},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.625},{"id":"https://openalex.org/keywords/washout-period","display_name":"washout period","score":0.37599998712539673}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9080468416213989},{"id":"https://openalex.org/C2781221834","wikidata":"https://www.wikidata.org/wiki/Q425360","display_name":"Factor IX","level":2,"score":0.5951476693153381},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5865480303764343},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.48163408041000366},{"id":"https://openalex.org/C2777902738","wikidata":"https://www.wikidata.org/wiki/Q1268495","display_name":"Breakthrough bleeding","level":5,"score":0.47216981649398804},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4496298134326935},{"id":"https://openalex.org/C2983523559","wikidata":"https://www.wikidata.org/wiki/Q410657","display_name":"On demand","level":2,"score":0.44547370076179504},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3960462808609009},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.09467089176177979},{"id":"https://openalex.org/C2986817661","wikidata":"https://www.wikidata.org/wiki/Q185698","display_name":"Research methodology","level":3,"score":0.0},{"id":"https://openalex.org/C49774154","wikidata":"https://www.wikidata.org/wiki/Q131765","display_name":"Multimedia","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C2779076696","wikidata":"https://www.wikidata.org/wiki/Q1280670","display_name":"Family planning","level":4,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v124.21.1523.1523","doi":"https://doi.org/10.1182/blood.v124.21.1523.1523","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.1523.1523","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2258158018","https://openalex.org/W3121231852","https://openalex.org/W2557138186","https://openalex.org/W2039878142","https://openalex.org/W2557382918","https://openalex.org/W2557473898","https://openalex.org/W3165387176","https://openalex.org/W4310276161","https://openalex.org/W6926631378","https://openalex.org/W2593592513"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Hemophilia":[2],"B":[3,70,189],"is":[4,43],"characterized":[5],"by":[6,226],"a":[7,44,82,104,251,297,405,439,444,492],"functional":[8],"deficiency":[9],"in":[10,16,46,54,108,125,162,306,363,396,404,503,512,556],"factor":[11],"IX":[12],"(FIX),":[13],"which":[14],"results":[15,360],"spontaneous":[17],"or":[18,32,38,93,205,442,688],"trauma-induced":[19],"bleeding":[20,52,111,282,298,385,411,550,618,636],"into":[21],"soft":[22],"tissue,":[23],"muscles,":[24],"and":[25,49,74,133,137,139,201,247,264,310,325,355,400,471,478,481,508,588],"joints.":[26],"Replacing":[27],"deficient":[28],"FIX":[29,34,85,199,207,256,311,440],"with":[30,56,64,98,119,152,159,164,183,213,229,416,431,538,553,558],"plasma-derived":[31],"recombinant":[33,83],"products,":[35,200],"either":[36],"prophylactically":[37],"on":[39,242,284,682],"an":[40,397,432,683],"on-demand":[41,99,120,160,211,294,380,486,554,657],"basis,":[42],"mainstay":[45],"the":[47,72,109,115,126,131,156,222,278,291,307,337,364,368,376,379,383,389,408,420,426,448,475,485,516,533,547],"prevention":[48],"treatment":[50,161,228,285,295,537,555],"of":[51,62,76,81,204,281,296,301,331,410,434,460,494,519,549,582,656,686],"episodes":[53],"patients":[55,63,163,322,335,347,352,489,557],"hemophilia":[57,69,169,188,563],"B.":[58,170,564],"A":[59],"previous":[60],"study":[61,102,175,332,527],"moderately":[65,165,184,559],"severe":[66,68,166,168,185,187,560,562],"to":[67,167,180,186,198,293,526,561],"compared":[71,118,158,552],"efficacy":[73,274],"safety":[75,138,576],"2":[77],"secondary":[78],"prophylaxis":[79,116,135,151,308,369,422,476,659],"regimens":[80,117],"coagulation":[84],"product":[86],"(nonacog":[87],"alfa,":[88],"50":[89],"IU/kg":[90,95,233,542,568,595],"twice":[91],"weekly":[92,235,544,570],"100":[94,232,541,567,594],"once":[96,234,543,569],"weekly)":[97],"treatment.":[100,660],"The":[101,272,450],"found":[103],"significant":[105,123],"reduction":[106],"(P<.0001)":[107,374],"annualized":[110],"rate":[112],"(ABR)":[113],"for":[114,144,216,236,367,378,654],"therapy.":[121],"No":[122,436,529],"differences":[124],"ABR":[127,157,279,359,366,377],"were":[128,142,260,323,348,353,357,429,457,578],"observed":[129],"between":[130],"once-weekly":[132,150],"twice-weekly":[134],"regimens,":[136],"tolerability":[140],"profiles":[141],"similar":[143],"both.":[145],"Objective:":[146],"To":[147],"demonstrate":[148],"that":[149],"nonacog":[153,214,230,269,539],"alfa":[154,215,231,270,540,566],"reduces":[155],"Methods:":[171],"This":[172],"open-label,":[173],"2-period":[174],"enrolled":[176,324],"males":[177],"aged":[178],"12":[179,237],"65":[181],"years":[182],"(FIX":[190],"plasma":[191],"activity":[192],"\u22642%),":[193],"\u2265100":[194],"prior":[195],"exposure":[196],"days":[197],"no":[202,574],"history":[203],"current":[206],"inhibitor.":[208],"Patients":[209],"received":[210,326],"therapy":[212],"6":[217,495,600],"months":[218],"(dose":[219],"selected":[220],"at":[221,265,327],"investigator's":[223],"discretion)":[224],"followed":[225],"prophylactic":[227],"months.":[238],"Recovery":[239],"was":[240,277,315,342,371,523,571],"assessed":[241],"day":[243],"1,":[244],"week":[245,248],"26,":[246],"78,":[249],"after":[250,268],"72-hour":[252],"washout":[253],"from":[254],"any":[255],"product.":[257],"Plasma":[258],"samples":[259],"collected":[261],"before":[262],"administration":[263,462],"30":[266],"minutes":[267],"infusion.":[271,418],"primary":[273],"end":[275,288],"point":[276],"(number":[280],"events/[days":[283],"period/365.25]).":[286],"Secondary":[287],"points":[289],"included":[290],"response":[292,399],"event,":[299],"incidence":[300],"less-than-expected":[302],"therapeutic":[303],"effect":[304],"(LETE)":[305],"setting;":[309],"inhibitor":[312,441],"development.":[313],"Safety":[314],"also":[316],"assessed.":[317],"Results:":[318],"In":[319],"total,":[320],"25":[321],"least":[328],"1":[329,417,513],"dose":[330],"medication;":[333],"all":[334],"completed":[336],"study.":[338,449,534],"Mean":[339,602,620,638],"\u00b1SD":[340],"age":[341],"31.3":[343],"\u00b112.6":[344],"years;":[345,350],"5":[346],"<18":[349],"9":[351],"Asian":[354],"16":[356],"white.":[358],"are":[361],"summarized":[362],"Table;":[365],"period":[370],"significantly":[372,545],"lower":[373],"than":[375],"period.":[381,487],"Of":[382,419],"507":[384],"events":[386,412,511,551,619,637],"treated":[387],"over":[388],"study,":[390,427],"271":[391],"(53.5%)":[392],"first":[393],"infusions":[394,423],"resulted":[395,403],"\u0093excellent\u0094":[398],"177":[401],"(34.9%)":[402],"\u0093good\u0094":[406],"response;":[407],"majority":[409],"(416/507;":[413],"82.1%)":[414],"resolved":[415],"1254":[421],"administered":[424],"during":[425,447,474,484,532],"none":[428],"associated":[430],"occurrence":[433],"LETE.":[435],"patient":[437],"developed":[438],"experienced":[443,491],"thrombotic":[445],"event":[446],"most":[451],"commonly":[452],"reported":[453],"treatment-emergent":[454],"AEs":[455],"(\u226520%)":[456],"inappropriate":[458],"schedule":[459],"drug":[461],"(24%),":[463],"arthralgia":[464,482],"(20%),":[465,470],"upper":[466],"respiratory":[467],"tract":[468],"infection":[469],"toothache":[472],"(20%)":[473,483,490],"period,":[477],"headache":[479],"(32%)":[480],"Five":[488],"total":[493],"serious":[496,517],"AEs;":[497],"blood":[498,520],"pressure":[499,521],"decreased,":[500],"pain":[501],"resulting":[502],"hospitalization,":[504],"chicken":[505],"pox,":[506],"lipoma,":[507],"nephrolithiasis":[509],"(2":[510],"patient).":[514],"Only":[515],"AE":[518],"decreased":[522],"considered":[524],"related":[525],"drug.":[528],"deaths":[530],"occurred":[531],"Conclusions:":[535],"Prophylactic":[536],"reduced":[546],"number":[548],"Nonacog":[565],"well":[572],"tolerated;":[573],"new":[575],"issues":[577],"observed.":[579],"Table.":[580],"Comparison":[581],"Annualized":[583],"Bleed":[584],"Rates":[585],"Between":[586],"On-Demand":[587,592],"Prophylaxis":[589,597],"Regimens":[590],"Parameter":[591],"(n=25)":[593,598],"Once-Weekly":[596],"Over":[599],"Months":[601],"(SD)":[603,621,639],"32.9":[604],"(17.4)":[605],"3.6":[606],"(4.6)*":[607],"Median":[608,626,644],"33.6":[609],"2.0":[610],"Minimum,":[611,629,647],"maximum":[612,630,648],"6.1,":[613],"69.0":[614],"0,":[615,631,633,649,651],"13.8":[616,634],"Spontaneous":[617],"23.1":[622],"(17.1)":[623],"2.6":[624],"(4.1)":[625],"22.4":[627],"1.0":[628,642,646],"54.2":[632],"Traumatic":[635],"9.9":[640],"(14.5)":[641],"(1.6)":[643],"4.1":[645],"52.2":[650],"6.9":[652],"*P<.0001":[653],"comparison":[655],"vs":[658],"Disclosures":[661],"Kavakli:":[662],"Pfizer":[663,666,675,679,694,704,718,728],"Inc.:":[664,667,676,680,692,695,702,705,712,719,722,726,729],"Honoraria;":[665],"Scientific":[668,671],"Congress":[669,672],"Expenses,":[670],"Expenses":[673],"Other;":[674,717],"Research":[677,723],"Funding;":[678],"Membership":[681],"entity's":[684],"Board":[685],"Directors":[687],"advisory":[689],"committees.":[690],"Smith:Pfizer":[691],"Employment;":[693,703,727],"Stock":[696,698,706,708,713,715,730,732],"Ownership,":[697,707,714,731],"Ownership":[699,709,716,733],"Other.":[700,710,734],"Korth-Bradley:Pfizer":[701],"Fuiman:Pfizer":[711],"Employment.":[720],"Zupancic-Salek:Pfizer":[721],"Funding.":[724],"Rendo:Pfizer":[725]},"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-12-08T00:00:00"}